In a large cohort (372 subjects) of patients undergoing hemodialysis, elevated plasma endostatin levels ( > 200 ng/mL) were independently associated with an increased risk of cardiovascular events such as acute coronary artery syndrome, heart failure, ventricular arrhythmia, cardiac arrest, and sudden death [157]. Here, COL18A1 is linked to heart failure.